Results of Metaregression Analysis of PET/MRI for Diagnosis of Locoregional HNSCC
Diagnostic indicators | |||||||
---|---|---|---|---|---|---|---|
Covariate | Category estimate | Number of studies | Sensitivity | P | Specificity | P | I2 (%) |
Study subjects | One HNSCC subtype | 2 | 100% (95% CI, 99%–100%) | 0.00 | 98% (95% CI, 95%–100%) | 0.68 | 81 |
Various HNSCC* subtype | 10 | 88% (95% CI, 81%–95%) | 95% (95% CI, 92%–98%) | ||||
Study design | Prospective | 5 | 94% (95% CI, 87%–100%) | 0.60 | 95% (95% CI, 91%–100%) | 0.26 | 0 |
Retrospective | 7 | 94% (95% CI, 83%–100%) | 96% (95% CI, 93%–100%) | ||||
MRI fusion | Simultaneous | 9 | 92% (95% CI, 85%–99%) | 0.27 | 96% (95% CI, 93%–99%) | 0.53 | 0 |
Retrospective | 3 | 96% (95% CI, 89%–100%) | 94% (95% CI, 85%–100%) | ||||
MRI acquisition | With DWI | 3 | 82% (95% CI, 61%–100%) | 0.08 | 93% (95% CI, 85%–100%) | 0.03 | 33 |
Without DWI | 9 | 95% (95% CI, 91%–100%) | 97% (95% CI, 94%–99%) | ||||
Reference standard | Pathologic | 5 | 90% (95% CI, 78%–100%) | 0.55 | 89% (95% CI, 80%–98%) | 0.92 | 67 |
Clinical and pathologic | 7 | 95% (95% CI, 89%–100%) | 98% (95% CI, 96%–99%) | ||||
QUADAS-2 risk | Presence | 5 | 97% (95% CI, 92%–100%) | 0.06 | 96% (95% CI, 91%–100%) | 0.26 | 16 |
Absence | 7 | 89% (95% CI, 79–99) | 96% (95% CI, 93%–99%) | ||||
Publication year | 4.87 | 0.69 | 0.96 | 59 |
↵* Various HNSCC refers to studies evaluating PET/MRI in patients with single primary HNSCC, regardless of its anatomic origin (more than one anatomic origin). Studies evaluating PET/MRI in patients with single primary HNSCC of similar anatomic origin, such as nasopharyngeal HNSCC, are referred to as one HNSCC subtype.